Latest Breaking News On - Ben larman - Page 1 : comparemela.com

Published: Apr 05, 2021     CAMBRIDGE, Mass. (BUSINESS WIRE) ImmuneID, Inc., a precision immunology company employing a proprietary platform to identify and therapeutically target antibody interactions that drive immune diseases, today announced that Annalisa D’Andrea, Ph.D., has been appointed President and Chief Scientific Officer. Dr. D’Andrea brings more than 25 years of experience in translational research in immunology to ImmuneID. “The addition of Annalisa as President and CSO is an important milestone for ImmuneID, as the company applies its platform to identify promising immunological therapeutic targets,” said Stephen Elledge, Ph.D., ImmuneID co-founder and Chair of ImmuneID SAB, Lasker Award winner, and The Gregor Mendel Professor of Genetics and Medicine, Harvard Medical School. “Annalisa’s experience advancing drug candidates to the clinic will be extremely valuable and I look forward to working with her.”

United kingdomPitango healthtechStephen elledge harvardAnnalisa dandreaTomasz kula harvardStephen elledgeBen larman johns hopkinsBachelor of sciencesKiniksa pharmaceuticalsLongwood fund christoph westphalHarvard medical schoolImmuneid incUniversity of sienaUniversity of pennsylvaniaUniversity of florenceLongwood fund